Trial Profile
A prospective, randomized, open-label parallel-group clinical study to investigate effects and maneuverability of devices of fluticasone/formoterol pMDI (Flutiform) vs. fluticasone/salmeterol DPI (Adoair Diskus) in patients who have poorly controlled asthma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Nov 2018
Price :
$35
*
At a glance
- Drugs Formoterol/fluticasone propionate (Primary) ; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Kyorin Pharmaceutical
- 12 Aug 2015 New trial record